1. Prosensa Outlines Next Steps for Drisapersen Program

    Posted on February 18, 20144:34 pm

    Leiden, February 18th , 2014 Dear Patient Group Representative, We hope this note finds you well. When we last communicated, we announced that Prosensa had regained all rights to drisapersen from GSK and retained the rights to the other DMD programs. Upon the announcement of the transfer of rights, GSK and Prosensa entered into a Read more »